FDA approves Eli Lilly's GLP-1 pill
CNBC · New
CNBC
New
The U.S. Food and Drug Administration has approved Eli Lilly's oral GLP-1 pill, Foundeo, which will be available for shipping from Lilly Direct and at pharmacies and telehealth platforms soon.
Breakdown
- FDA approves Eli Lilly's oral GLP-1 pill, now named Foundeo 3s
- Foundeo will ship soon and be available at pharmacies and telehealth platforms 11s
- Pricing set at $25/month with insurance, $149–$349/month out-of-pocket 52s
- Medicare patients can access Foundeo for $50/month starting in July 1m 8s
- Foundeo is less effective than weekly injections but easier to take than rival pills 1m 16s